Device / Technology News

RSS

Boston Scientific introduces new Kinetix Guidewire for use in PCI procedures

Boston Scientific Corporation today announced the launch of its new Kinetix™ Guidewire for use in percutaneous coronary intervention (PCI) procedures. Guidewires are small flexible wires physicians use to deliver interventional devices such as drug-eluting stents. The Kinetix Guidewire features a unique micro-cut nitinol sleeve designed for significantly improved torque control compared to conventional spring coil guidewires.

23 Apr 2010

Website launched to track aid to Haiti from 'pledge to impact'

Agence France-Presse reports that the U.N. has launched "a new website to track the estimated 9.9 billion dollars in aid pledged to Haiti by the international community in the wake of a devastating January 12 earthquake." The website is a joint project of the Haitian government and the U.N. Development Programme.

23 Apr 2010

Align Technology reports 28.5% increase year-over-year in first-quarter revenues

Align Technology, Inc. today reported financial results for the first quarter of fiscal 2010, ended March 31, 2010.

22 Apr 2010

Mystic Pharmaceuticals granted U.S. patent covering VRx2 drug delivery platform technology

Mystic Pharmaceuticals today announced it has been granted U.S. Patent 7,669,597, a key technology of its VRx2™ drug delivery platform. The VRx2™ Delivery Platform provides preservative free, precision dose delivery for ophthalmic and intranasal drugs and biologics.

22 Apr 2010

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

Baxter International Inc. today reported first quarter net income of $525 million, an increase of 2 percent from $516 million reported in the first quarter of 2009. Earnings per diluted share of $0.86 increased 4 percent from $0.83 per diluted share reported in the prior-year period. Baxter's first quarter financial results included a one-time, non-cash special charge of $39 million (or $0.07 per diluted share) related to a change in the tax treatment of post-retirement prescription drug benefits under recent U.S. healthcare reform legislation.

From Baxter International Inc. 22 Apr 2010

New gene therapy to restore retinal cone function and day vision

Veterinary ophthalmology researchers from the University of Pennsylvania have used gene therapy to restore retinal cone function and day vision in two canine models of congenital achromatopsia, also called rod monochromacy or total color blindness.

22 Apr 2010

Interventional Spine to present at and participate as sponsor of Spine Technology Summit

Interventional Spine, Inc., a privately held medical device manufacturer focusing on diseases of the spine, will present at the Spine Technology Summit at the Roosevelt Hotel in New Orleans on Monday April 26th. This annual event is a showcase for 40 new technology companies and attracts investors, industry, practitioners and analysts.

22 Apr 2010

CancerDrugsDirect.com provides customers access to affordable cancer medications

When someone is diagnosed with cancer, the effects can be devastating both physically as well as financially. Recent studies have shown that many cancer patients are foregoing care because of the skyrocketing cost of cancer treatments.

22 Apr 2010

Life sciences companies shifting away from traditional document management systems to emerging ECC solutions

Virtify, Inc., today announced the availability of a new IDC Health Insights study titled "Managing Paper at Its Roots: Extending Beyond Document Management to Enterprise Content Compliance." The new IDC Health Insights study, which was commissioned by Virtify, shows a growing trend in the life sciences industry away from traditional document management systems to emerging Enterprise Content Compliance (ECC) solutions.

22 Apr 2010

A-Life Medical signs exclusive agreement with Drs. Hill & Thomas

A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding products and services to the healthcare industry, announced today the forging of an exclusive agreement with the oldest and largest independently owned radiology group in Ohio, Cleveland-based Drs. Hill & Thomas Co.

22 Apr 2010

Enigma ML instrument system to be showcased at InnovHealth 2010 summit

Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today that it will be a product provider at the InnovHealth - Middle East Healthcare Innovations Summit in Abu Dhabi on 25 and 26 April 2010 and will be presenting the Enigma ("Mini Laboratory") instrument system.

22 Apr 2010

Canadian physicians have increased the use of clinical and pharmaceutical information: Study

New results from the Essential Physician Version 2.0 study indicate primary care physicians are changing the way they access and use clinical and pharmaceutical information. Physicians increasingly access online resources for relevant information they need on demand, even during and between patient visits.

22 Apr 2010

Gen-Probe's PROGENSA PCA3 assay helps determine necessity of initial biopsy in prostate cancer suspect men

Gen-Probe's PROGENSA® PCA3 assay can help predict the outcome of initial prostate biopsies in men suspected of having prostate cancer, according to a study of the molecular urine test presented in a scientific poster last week at the 25th annual European Association of Urology (EAU) Congress in Barcelona, Spain.

22 Apr 2010

Autonomy, Kainos release Evolve Electronic Document Management solution

Autonomy Corporation plc, a global leader in infrastructure software for the enterprise, and Kainos, a leading IT consulting company, today announced the launch of Evolve™, a next-generation Electronic Document Management solution which enables instant and secure access to patient medical records through Autonomy's unique Meaning Based Computing solutions. The new system is already being trail blazed by Ipswich Hospital NHS Trust and is the successful outcome of months of collaboration between Kainos and Autonomy.

22 Apr 2010

WaferGen Biosystems introduces SmartChip Multi-Sample Dispenser for faster biomarker validation

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genetic analysis systems, today announced that it has launched its SmartChip Multi-Sample Dispenser to enable significant speed and cost advantages for biomarker validation using gene expression and genotyping. The new SmartChip Multi-Sample Dispenser, which is part of the SmartChip Real-Time PCR System, can load up to 384 samples or sample replicates on a single SmartChip with its 5,184 nanowells, offering the highest number of samples that can be run on a nano-chip.

22 Apr 2010

Medical technology innovation strives for personal focus, cost-efficiency

Medtronic CEO Bill Hawkins says the products made by his company, like pacemakers, insulin pumps and neurostimulators are the "ultimate personal technologies," according to CNNMoney. He said a shift in his industry is moving towards health information technology that people will depend on and use with their cell phones and laptops.

22 Apr 2010

Manhattan Scientifics' early cancer detection technology offers better results than mammogram test

Manhattan Scientifics, Inc. announced today that its "early cancer detection" technology, developed by Edward R. Flynn, Ph.D. is expected to identify breast cancer three years earlier than the current gold standard mammogram test. Dr. Flynn is a pioneer in the emerging field of nano medicine.

22 Apr 2010

Non-invasive coronary CTA cost-effective alternative to invasive cardiac catheterization for CAD evaluation

According to a study conducted at Thomas Jefferson University (TJU), non-invasive coronary computed tomography angiography (CTA) is a cost-effective alternative to invasive cardiac catheterization in the care of patients who have positive stress test results but a less than 50 percent chance of actually having significant coronary artery disease (CAD). The study will be published in the May issue of the American Journal of Roentgenology.

22 Apr 2010

MedAssets, Cullman Regional Medical Center announce transformational revenue cycle agreement

MedAssets, Inc. today announced that it entered into a transformational revenue cycle agreement with Cullman Regional Medical Center, based in Cullman, Ala. to improve the provider's business office operations.

22 Apr 2010

Genmab introduces new pre-clinical antibody program and novel bispecific antibody technology

Genmab A/S will announce today at its Annual General Meeting a new pre-clinical antibody program, HuMax-cMet,as well as a novel next generation bispecific antibody technology.

22 Apr 2010

Device / Technology News

Boston Scientific introduces new Kinetix Guidewire for use in PCI procedures

Website launched to track aid to Haiti from 'pledge to impact'

Align Technology reports 28.5% increase year-over-year in first-quarter revenues

Mystic Pharmaceuticals granted U.S. patent covering VRx2 drug delivery platform technology

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

New gene therapy to restore retinal cone function and day vision

Interventional Spine to present at and participate as sponsor of Spine Technology Summit

CancerDrugsDirect.com provides customers access to affordable cancer medications

Life sciences companies shifting away from traditional document management systems to emerging ECC solutions

A-Life Medical signs exclusive agreement with Drs. Hill & Thomas

Enigma ML instrument system to be showcased at InnovHealth 2010 summit

Canadian physicians have increased the use of clinical and pharmaceutical information: Study

Gen-Probe's PROGENSA PCA3 assay helps determine necessity of initial biopsy in prostate cancer suspect men

Autonomy, Kainos release Evolve Electronic Document Management solution

WaferGen Biosystems introduces SmartChip Multi-Sample Dispenser for faster biomarker validation

Medical technology innovation strives for personal focus, cost-efficiency

Manhattan Scientifics' early cancer detection technology offers better results than mammogram test

Non-invasive coronary CTA cost-effective alternative to invasive cardiac catheterization for CAD evaluation

MedAssets, Cullman Regional Medical Center announce transformational revenue cycle agreement

Genmab introduces new pre-clinical antibody program and novel bispecific antibody technology

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News